Shepard C C, Walker L L, Van Landingham R M
Infect Immun. 1978 Feb;19(2):391-4. doi: 10.1128/iai.19.2.391-394.1978.
Viable suspensions of BCG, an attenuated strain of Mycobacterium bovis, have been previously shown to immunize mice against infections with M. leprae. Usually, the mice have been vaccinated about 1 month before challenge. Experiments have now been carried out with single intradermal injections of BCG given before or after the M. leprae challenge. Approximately equal immunizing effect was seen in one experiment when the BCG was given at -168, -119, -70, and -28 days relative to challenge. Approximately equal protection was observed in another experiment when the vaccine was given at -28, +28, and +56 days. In the latter experiment, however, vaccine given at +91 days appeared to be somewhat less effective. Enlargement of the lymph nodes regional to the intradermal vaccine site persisted for at least the duration of the experiment, approximately 400 days. Thus, antigenic stimulation appears to have continued throughout the period of observation.
减毒牛分枝杆菌卡介苗(BCG)的活悬液先前已被证明可使小鼠对麻风分枝杆菌感染产生免疫。通常,小鼠在攻击前约1个月接种疫苗。现在已经进行了实验,在麻风分枝杆菌攻击之前或之后进行单次皮内注射BCG。在一项实验中,相对于攻击,在-168、-119、-70和-28天给予BCG时,观察到了大致相同的免疫效果。在另一项实验中,当在-28、+28和+56天给予疫苗时,观察到了大致相同的保护作用。然而,在后一项实验中,在+91天给予的疫苗似乎效果稍差。皮内疫苗接种部位区域的淋巴结肿大至少持续了实验的持续时间,约400天。因此,在整个观察期间,抗原刺激似乎一直在持续。